1447121-20-1

Basic information

• Product Name: N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine trifluoroacetate
• CAS NO: 1447121-20-1
• Molecular Weight: 554.563
• Mol File: 1447121-20-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine trifluoroacetate(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine trifluoroacetate(1447121-20-1)
• EPA Substance Registry System: N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine trifluoroacetate(1447121-20-1)

Safety Data

• Hazardous Substances Data: 1447121-20-1(Hazardous Substances Data)

Upstream product

• 13333-79-4 3-fluoro-4-(methylthio)phenol 
• 20901-69-3 3-fluoro-4-(methylthio)benzeneamine 
• 369-34-6 3,4-difluoronitrobenzene 
• 372121-91-0 (2-fluoro-4-nitrophenyl)(methyl)sulfone 
• 1447121-17-6 N-(2-(3-fluoro-4-(methylsulfonyl)phenoxy)ethyl)-1-(3-isopropyl-1,2,4-oxadiazol-5-yl)-N-methylpiperidine-4-amine 
• 76-05-1 trifluoroacetic acid 

Relevant articles and documents

SUBSTITUTED PIPERIDINE DERIVATIVES AND METHODS FOR PREPARING THE SAME

The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof, a preparation method thereof and a pharmaceutical composition for treating metabolism-related disorder containing the same. Specifically, the present invention relates to a compound of the formula 1, which can activate GPR119 to treat metabolism-related disorders, including diabetes and related diseases, diabetes-related microvascular complications, diabetes-related macrovascular complications, cardiovascular abnormalities, metabolic syndrome and its constituent diseases, and obesity.